Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 16, 2024BMC Cardiovascular DisordersOpen Access

Catheter ablation versus antiarrhythmic drug therapy for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy

View Full Paper
Ask AI
Bookmark
Share

Authors

YDYan DongXSXudong SongDBDan Bo

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Dong et al. (2024) studied this question.

synapsesocial.com/papers/68e69c3ab6db643587621ba2https://doi.org/10.1186/s12872-024-03924-w
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Long-term outcomes of catheter ablation for sustained ventricular tachycardia in patients with hypertrophic cardiomyopathy2026
  2. 2Clinical outcomes of radiofrequency catheter ablation of ventricular tachycardia in patients with hypertrophic cardiomyopathy2022 · 18 citations
  3. 3Clinical Outcomes of Catheter Ablation for Atrial Fibrillation in Patients With Hypertrophic Cardiomyopathy2026
  4. 4Catheter Ablation Versus Antiarrhythmic Drugs in the Management of Ventricular Tachycardia in Ischemic Cardiomyopathy: An Updated Systematic Review and Meta-analysis2026
  5. 5Catheter ablation versus antiarrhythmic drugs in patients with ventricular tachycardia and ischemic cardiomyopathy: a meta-analysis of randomized controlled trials2025